X-ray-induced radiophotodynamic therapy (RPDT) using lanthanide micelles: Beyond depth limitations

Nano Research

Volumn 8, Issue 7, 2015, Pages 2373-2379

  Kaščáková, Slávka ^a,b   Giuliani, Alexandre ^a,c   Lacerda, Sara ^d   Pallier, Agnès ^d   Mercère, Pascal ^a   Tóth, Éva ^d   Réfrégiers, Matthieu ^a  

^a SYNCHROTRON SOLEIL   (France)

^b Universite Paris Sud   (France)

^c CEMAGREF   (France)

^d CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

Author keywords

deep tumour; liponanoparticles; photodynamic therapy; photosensitizer; X ray

Indexed keywords

EID: 84937965954     PISSN: 19980124     EISSN: 19980000     Source Type: Journal    
DOI: 10.1007/s12274-015-0747-5     Document Type: Article

References (38)

1. Setua, S.; Menon, D.; Asok, A.; Nair S.; Koyakutty, M. Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells. Biomaterials2010, 31, 714–729.
2. Bünzli, J. C. G.; Piguet, C. Taking advantage of luminescent lanthanide ions. Chem. Soc. Rev. 2005, 34, 1048–1077.
3. Bruchez, M.; Moronne, M.; Gin, P.; Weiss, S.; Alivisatos, A. P. Semiconductor nanocrystals as fluorescent biological labels. Science1998, 281, 2013–2016.
4. Chan, W. C. W.; Nie, S. M. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science1998, 281, 2016–2018.
5. Delehanty, J. B.; Bradburne, C. E.; Susumu, K.; Boeneman, K.; Mei, B. C.; Farrell, D.; Blanco-Canosa, J. B.; Dawson, P. E.; Mattoussi, H.; Medintz, I. L. Spatiotemporal multicolor labeling of individual cells using peptide-functionalized quantum dots and mixed delivery techniques. J. Am. Chem. Soc. 2011, 133, 10482–10489.
6. Pinaud, F.; Clarke, S.; Sittner, A.; Dahan, M. Probing cellular events, one quantum dot at a time. Nat. Methods2010, 7, 275–285.
7. Faulkner, S.; Pope, S. J. A.; Burton-Pye, B. P. Lanthanide complexes for luminescence imaging applications. Appl. Spectrosc. Rev. 2005, 40, 1–31.
8. LaVan, D. A.; McGuire, T.; Langer, R. Small-scale systems for in vivo drug delivery. Nat. Biotechnol. 2003, 21, 1184–1191.
9. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in cancer therapy and diagnosis. Adv. Drug Delivery Rev. 2002, 54, 631–651.
10. Xie, J.; Lee, S.; Chen, X. Y. Nanoparticle-based theranostic agents. Adv. Drug Delivery Rev. 2010, 62, 1064–1079.
11. Caravan, P.; Ellison, J. J.; McMurry, T. J.; Lauffer, R. B. Gadolinium (III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev. 1999, 99, 2293–2352.
12. Zhou, Z. X.; Lu, Z. R. Gadolinium-based contrast agents for magnetic resonance cancer imaging. Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2013, 5, 1–18.
13. Merbach, A. S.; Helm, L. Toth, E. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging; John Wiley & Sons, Ltd: Chichester, West Sussex, UK, 2013.
14. Maguire, J. A.; Zhu, Y. Boron and Gadolinium Neutron Capture Therapy for Cancer Treatment; World Scientific Pub. Co.: Hackensack, NJ, 2012.
15. Eliseeva, S. V.; Bünzli, J. C. G. Lanthanide luminescence for functional materials and bio-sciences. Chem. Soc. Rev. 2010, 39, 189–227.
16. Werts, M. H. V. Making sense of lanthanide luminescence. Sci. Prog. 2005, 88, 101–131.
17. Urbain, G. La phosphorescence cathodique des terres rares. Ann. Chim. Phys. 1909, 8, 222–375.
18. Kašcáková, S.; Giuliani, A.; Jamme, F.; Refregiers, M. Photodynamic Therapy. In Radiation Damage in Biomolecular Systems; Springer: Dordrecht, Heidelberg, London, New York, 2012; pp 445–460.
19. Roelants, M.; Lackner, B.; Waser, M.; Falk, H.; Agostinis, P.; Van Poppel, H.; de Witte, P. A. M. In vitro study of the phototoxicity of bathochromically-shifted hypericin derivatives. Photochem. Photobiol. Sci. 2009, 8, 822–829.
20. Carpenter, S.; Fehr, M. J.; Kraus, G. A.; Petrich, J. W. Chemiluminescent activation of the antiviral activity of hypericin: A molecular flashlight. Proc. Natl. Acad. Sci. USA1994, 91, 12273–12277.
21. Wen, J.; Chowdhury, P.; Wills, N. J.; Wannemuehler, Y.; Park, J.; Kesavan, S.; Carpenter, S.; Kraus, G. A.; Petrich, J. W. Toward the molecular flashlight: Preparation, properties and photophysics of a hypericin-luciferin tethered molecule. Photochem. Photobiol. 2002, 76, 153–157.
22. Theodossiou, T.; Hothersall, J. S.; Woods, E. A.; Okkenhaug, K.; Jacobson, J.; MacRobert, A. J. Firefly luciferin-activated rose bengal: In vitro photodynamic therapy by intracellular chemiluminescence in transgenic NIH 3T3 cells. Cancer Res. 2003, 63, 1818–1821.
23. 3+ nanocrystals. J. Mater. Chem. 2006, 16, 1031–1034.
24. 3+ water-soluble nanoparticles. J. Appl. Phys. 2008, 103, 063105.
25. Liu, Y. F.; Chen, W.; Wang, S. P.; Joly, A. G. Investigation of water-soluble X-ray luminescence nanoparticles for photodynamic activation. Appl. Phys. Lett. 2008, 92, 043901.
26. Bulin, A. L.; Truillet, C.; Chouikrat, R.; Lux, F.; Frochot, C.; Amans, D.; Ledoux, G.; Tillement, O.; Perriat, P.; Barberi-Heyob, M. et. al. X-ray-induced singlet oxygen activation with nanoscintillator-coupled porphyins. J. Phys. Chem. C2013, 117, 21583–21589.
27. Ma, L.; Zou, X.; Chen, W. A new X-ray activated nanoparticle photosensitizer for cancer treatment. J. Biomed. Nanotechnol. 2014, 10, 1501–1508.
28. Ma, L.; Zou, X. J.; Bui, B.; Chen, W.; Song, K. H.; Solberg, T. X-ray excited ZnS: Cu, Co afterglow nanoparticles for photodynamic activation. Appl. Phys. Lett. 2014, 105, 013702.
29. Bonnet, C. S.; Pellegatti, L.; Buron, F.; Shade, C. M.; Villette, S.; Kubícek, V.; Guillaumet, G.; Suzenet, F.; Petoud, S.; Tóth, É. Hydrophobic chromophore cargo in micellar structures: A different strategy to sensitize lanthanide cations. Chem. Commun.2010, 46, 124–126.
30. Bonnet, C. S.; Buron, F.; Caillé, F., Shade, C. M.; Drahoš, B.; Pellegatti, L.; Zhang, J.; Villette, S.; Helm, L.; Pichon, C. et. al. Pyridine-based lanthanide complexes combining MRI and NIR luminescence activities. Chem.—Eur. J. 2012, 18, 1419–1431.
31. 3+ in dimethylsulfoxide (DMSO). J. Lumin. 1974, 9, 79–93.
32. 5:Ce,Tb. Opt. Mater. (Amst). 2007, 29, 1023–1028.
33. Armelao, L.; Heigl, F.; Jürgensen, A.; Blyth, R. I. R.; Regier, T.; Zhou, X. T.; Sham, T. K. X-ray excited optical luminescence studies of ZnO and Eu-doped ZnO nanostructures. J. Phys. Chem. C2007, 111, 10194–10200.
34. Trans-1-(2'-methoxyvinyl)pyrene. http://products.invitrogen. com/ivgn/product/M7913 (accessed Dec 24, 2014).
35. Kascakova, S.; Refregiers, M.; Jancura, D.; Sureau, F.; Maurizot, J. C.; Miskovsky, P. High level of low-density lipoprotein receptors enhance hypericin uptake by U-87 MG cells in the presence of LDL. Photochem. Photobiol. 2005, 81, 1395–1403.
36. Giuliani, A.; Jamme, F.; Rouam, V.; Wien, F.; Giorgetta, J. L.; Lagarde, B.; Chubar, O.; Bac, S.; Yao, I.; Rey, S. et al. DISCO: A low-energy multipurpose beamline at synchrotron SOLEIL. J. Synchrotron Radiat. 2009, 16, 835–841.
37. Jamme, F.; Villette, S.; Giuliani, A.; Rouam, V.; Wien, F.; Lagarde, B.; Réfrégiers, M. Synchrotron UV fluorescence microscopy uncovers new probes in cells and tissues. Microsc. Microanal. 2010, 16, 507–514.
38. Edelstein, A.; Amodaj, N.; Hoover, K.; Vale, R.; Stuurman, N. Computer control of microscopes using micromanager. Curr. Protoc. Mol. Biol. 2010, 92, 14.20.1–14.20.17.